When is crossover desirable in cancer drug trials and when is it problematic?
Author:
Publisher
Elsevier BV
Subject
Oncology,Hematology
Link
http://academic.oup.com/annonc/article-pdf/29/5/1079/25083293/mdy116.pdf
Reference14 articles.
1. Epidemiology and reporting of randomised trials published in PubMed journals;Chan;Lancet,2005
2. Crossover is not associated with faster trial accrual;Chen;Ann Oncol,2018
3. Treatment switching in cancer trials: issues and proposals;Henshall;Int J Technol Assess Health Care,2016
4. Double-crossed: why crossover in clinical trials may be distorting medical science;Prasad;J Natl Compr Canc Netw,2013
5. The misguided ethics of crossover trials;Prasad;Contemp Clinl Trials,2014
Cited by 35 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Current unmet needs in locally advanced (unresectable) or metastatic dedifferentiated liposarcoma, the relevance of progression-free survival as clinical endpoint, and expectations for future clinical trial design: an international Delphi consensus report;ESMO Open;2024-07
2. Design issues with lutetium-177 PSMA-617 registration studies that bias the outcome of the experimental arm reflect an increasing misalignment of contemporary oncology trials with true patient benefit;BJC Reports;2024-06-24
3. INDIGO: Example of inappropriate crossover and why PFS cannot be the primary outcome in gliomas;Journal of Cancer Policy;2024-06
4. The need for optimal crossover in trials testing the anticipation of treatments: A methodological and ethical issue;Cancer;2024-05-28
5. Clinical trial design and treatment effects: a meta-analysis of randomised controlled and single-arm trials supporting 437 FDA approvals of cancer drugs and indications;BMJ Evidence-Based Medicine;2024-05-17
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3